Filtros de búsqueda

Lista de obras de

11CEnzastaurin, the first design and radiosynthesis of a new potential PET agent for imaging of protein kinase C ⬇️

artículo científico publicado el 31 de enero de 2011

11CGSK2126458 and 18FGSK2126458, the first radiosynthesis of new potential PET agents for imaging of PI3K and mTOR in cancers ⬇️

artículo científico publicado el 10 de enero de 2012

2-methoxyestradiol inhibits the anaphase-promoting complex and protein translation in human breast cancer cells

artículo científico

A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast ⬇️

artículo científico publicado el 2 de mayo de 2013

A Phase I/II study of suberoylanilide hydroxamic acid (SAHA) in combination with trastuzumab (Herceptin) in patients with advanced metastatic and/or local chest wall recurrent HER2-amplified breast cancer: a trial of the ECOG-ACRIN Cancer Research G

artículo científico publicado en 2017

A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale

scientific article published on 01 September 2004

A comparative proteomic study to characterize the vinblastine resistance in human ovarian cancer cells.

artículo científico publicado en 2006

A multicenter phase II trial of ZD6474, a vascular endothelial growth factor receptor-2 and epidermal growth factor receptor tyrosine kinase inhibitor, in patients with previously treated metastatic breast cancer

artículo científico publicado en 2005

A phase I-II study of combined blockade of the ErbB receptor network with trastuzumab and gefitinib in patients with HER2 (ErbB2)-overexpressing metastatic breast cancer

artículo científico publicado en 2008

A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer ⬇️

artículo científico publicado el 1 de octubre de 2003

A phase II study of 9-nitro-camptothecin in patients with previously treated metastatic breast cancer

artículo científico publicado en 2004

A phase II study of oral enzastaurin in patients with metastatic breast cancer previously treated with an anthracycline and a taxane containing regimen

artículo científico publicado en 2009

A phase II trial of capecitabine in combination with the farnesyltransferase inhibitor tipifarnib in patients with anthracycline-treated and taxane-resistant metastatic breast cancer: an Eastern Cooperative Oncology Group Study (E1103) ⬇️

artículo científico publicado el 1 de mayo de 2012

A phase II trial of trastuzumab plus weekly ixabepilone and carboplatin in patients with HER2-positive metastatic breast cancer: an Eastern Cooperative Oncology Group Trial

artículo científico publicado en 2010

A physiologic imaging pilot study of breast cancer treated with AZD2171.

artículo científico publicado en 2006

A randomized phase II feasibility trial of BMS-275291 in patients with early stage breast cancer

artículo científico publicado en 2004

A randomized trial of combination anastrozole plus gefitinib and of combination fulvestrant plus gefitinib in the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer ⬇️

artículo científico publicado el 15 de marzo de 2012

ASCO's approach to a learning health care system in oncology.

artículo científico publicado en 2013

Abstract OT1-1-07: A phase III study of abemaciclib (LY2835219) combined with fulvestrant in women with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) breast cancer (MONARCH 2)

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer

article

An intervention to improve communication between breast cancer survivors and their physicians.

artículo científico publicado en 2010

Analysis of Overall Survival Benefit of Abemaciclib Plus Fulvestrant in Hormone Receptor-Positive, ERBB2-Negative Breast Cancer-Reply

artículo científico publicado en 2020

Analysis of angiogenesis genes from paraffin-embedded breast tumor and lymph nodes

artículo científico publicado en 2006

Angiogenesis and antiangiogenic therapy.

artículo científico publicado en 2002

Angiogenesis as targeted breast cancer therapy

artículo científico publicado en 2007

Anti–Vascular Endothelial Growth Factor Therapy for Breast Cancer: Can We Pick the Winners? ⬇️

artículo científico publicado el 9 de mayo de 2011

Association of Circulating Tumor Cells With Late Recurrence of Estrogen Receptor-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial

scientific article published on 01 December 2018

Association of polymorphisms of angiogenesis genes with breast cancer

artículo científico publicado en 2007

Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100.

artículo científico publicado en 2008

Avoidant coping and self-efficacy mediate relationships between perceived social constraints and symptoms among long-term breast cancer survivors

artículo científico publicado en 2016

Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103.

artículo científico publicado en 2014

C-MYC alterations and association with patient outcome in early-stage HER2-positive breast cancer from the north central cancer treatment group N9831 adjuvant trastuzumab trial.

artículo científico publicado en 2011

Can tumor angiogenesis be inhibited without resistance?

artículo científico publicado en 2005

Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial

artículo científico publicado en 2008

Change in Survival in Metastatic Breast Cancer with Treatment Advances: Meta-Analysis and Systematic Review

scholarly article published November 2018

Characterizing the heterogeneity of triple-negative breast cancers using microdissected normal ductal epithelium and RNA-sequencing.

artículo científico publicado en 2013

Charcot-Marie-Tooth gene, SBF2, associated with taxane-induced peripheral neuropathy in African Americans

artículo científico publicado en 2016

Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical Trial

scientific article published on 30 September 2019

Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer

scientific article published on 03 June 2019

Cognitive function in breast cancer survivors compared to healthy age- and education-matched women

artículo científico publicado en 2009

Comparative studies of potential cancer biomarkers carbon-11 labeled MMP inhibitors (S)-2-(4'-[11C]methoxybiphenyl-4-sulfonylamino)-3-methylbutyric acid and N-hydroxy-(R)-2-[[(4'-[11C]methoxyphenyl)sulfonyl]benzylamino]-3-methylbutanamide

artículo científico publicado en 2004

Comparison of computational algorithms for the classification of liver cancer using SELDI mass spectrometry: a case study

artículo científico publicado en 2007

Comparison of younger and older breast cancer survivors and age-matched controls on specific and overall quality of life domains

artículo científico publicado en 2014

Consensus statement: Expedition Inspiration 2004 Breast Cancer Symposium ?Breast Cancer ? the Development and Validation of New Therapeutics?

article

Cytochrome P450 Polymorphisms and their Relationship with Premature Ovarian Failure in Premenopausal Women with Breast Cancer Receiving Doxorubicin and Cyclophosphamide ⬇️

artículo científico publicado el 9 de agosto de 2011

DNA double-strand break repair genes and oxidative damage in brain metastasis of breast cancer

artículo científico publicado en 2014

Design and synthesis of carbon-11-labeled dual aromatase-steroid sulfatase inhibitors as new potential PET agents for imaging of aromatase and steroid sulfatase expression in breast cancer.

artículo científico publicado en 2009

Development and psychometric testing of a breast cancer survivor self-efficacy scale

artículo científico publicado en 2013

Differential subcellular expression of protein kinase C betaII in breast cancer: correlation with breast cancer subtypes

artículo científico publicado en 2010

Does biomarker information impact breast cancer patients' preferences and physician recommendation for adjuvant chemotherapy?

artículo científico publicado en 2017

Double-Blind Phase III Trial of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node-Positive and High-Risk Lymph Node-Negative Breast Cancer (E5103)

artículo científico publicado en 2018

Effect of Unblinding on Participants' Perceptions of Risk and Confidence in a Large Double-Blind Clinical Trial of Chemotherapy for Breast Cancer

artículo científico publicado en 2015

Effects of Celecoxib and Low-dose Aspirin on Outcomes in Adjuvant Aromatase Inhibitor-Treated Patients: CCTG MA.27.

artículo científico publicado en 2018

Effects of HIV protease inhibitor ritonavir on Akt-regulated cell proliferation in breast cancer

artículo científico publicado en 2006

Establishment and characterization of a novel cell line derived from human thymoma AB tumor

artículo científico publicado en 2012

Estrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory

artículo científico publicado en 2008

Evaluation of tumor response, disease control, progression-free survival, and time to progression as potential surrogate end points in metastatic breast cancer.

artículo científico publicado en 2008

Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27--a randomized controlled phase III trial

artículo científico publicado en 2013

Exploratory study evaluating the association of polymorphisms of angiogenesis genes with hot flashes

artículo científico publicado en 2008

Facile synthesis of carbon-11-labeled cholesterol-based cationic lipids as new potential PET probes for imaging of gene delivery in cancer

artículo científico publicado en 2010

Gene Expression Analysis Reveals Distinct Pathways of Resistance to Bevacizumab in Xenograft Models of Human ER-Positive Breast Cancer

artículo científico publicado en 2014

Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199.

artículo científico publicado en 2015

Genome-Wide Association Study for Anthracycline-Induced Congestive Heart Failure

artículo científico publicado en 2016

Genomic analysis reveals that immune function genes are strongly linked to clinical outcome in the North Central Cancer Treatment Group n9831 Adjuvant Trastuzumab Trial.

artículo científico publicado en 2015

HER2 and chromosome 17 effect on patient outcome in the N9831 adjuvant trastuzumab trial

artículo científico publicado en 2010

Health-Related Quality of Life in MONARCH 2: Abemaciclib plus Fulvestrant in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer After Endocrine Therapy

scientific article published on 24 October 2019

Higher Absolute Lymphocyte Counts Predict Lower Mortality from Early-Stage Triple-Negative Breast Cancer

scientific article published on 26 March 2018

Identification and validation of genes with expression patterns inverse to multiple metastasis suppressor genes in breast cancer cell lines

artículo científico publicado en 2014

Identification of FDA-approved drugs targeting breast cancer stem cells along with biomarkers of sensitivity.

artículo científico publicado en 2013

Impact of Genetic Ancestry on Outcomes in ECOG-ACRIN-E5103

artículo científico publicado en 2017

Impact of PTEN protein expression on benefit from adjuvant trastuzumab in early-stage human epidermal growth factor receptor 2-positive breast cancer in the North Central Cancer Treatment Group N9831 trial

artículo científico publicado en 2013

Impact of c-MYC protein expression on outcome of patients with early-stage HER2+ breast cancer treated with adjuvant trastuzumab NCCTG (alliance) N9831.

artículo científico publicado en 2013

Impact of insurance and neighborhood socioeconomic status on clinical outcomes in therapeutic clinical trials for breast cancer

scientific article published on 02 December 2020

Integrated digital error suppression for improved detection of circulating tumor DNA

artículo científico publicado en 2016

Investigational drug MLN0128, a novel TORC1/2 inhibitor, demonstrates potent oral antitumor activity in human breast cancer xenograft models ⬇️

artículo científico publicado el 21 de octubre de 2012

Liquid biopsy enters the clinic — implementation issues and future challenges

artículo científico publicado en 2021

Long-Term Follow-Up of the E1199 Phase III Trial Evaluating the Role of Taxane and Schedule in Operable Breast Cancer

artículo científico publicado en 2015

MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2- Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy.

artículo científico

Molecular Characterization and Mortality From Breast Cancer in Men

artículo científico publicado en 2018

Molecular analysis of thymoma.

artículo científico publicado en 2012

Multiplexed assessment of the Southwest Oncology Group-directed Intergroup Breast Cancer Trial S9313 by AQUA shows that both high and low levels of HER2 are associated with poor outcome

artículo científico publicado en 2010

Neuropathy is not associated with clinical outcomes in patients receiving adjuvant taxane-containing therapy for operable breast cancer

artículo científico publicado en 2012

Nodular Regenerative Hyperplasia After Treatment With Trastuzumab Emtansine

artículo científico publicado en 2014

Obesity at diagnosis is associated with inferior outcomes in hormone receptor‐positive operable breast cancer ⬇️

artículo científico publicado el 27 de agosto de 2012

Osteoporosis therapy and outcomes for postmenopausal patients with hormone receptor-positive breast cancer: NCIC CTG MA.27.

artículo científico publicado en 2017

Outcome of patients with early-stage breast cancer treated with doxorubicin-based adjuvant chemotherapy as a function of HER2 and TOP2A status

artículo científico publicado en 2009

Overall Survival Benefit With Lapatinib in Combination With Trastuzumab for Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: Final Results From the EGF104900 Study ⬇️

artículo científico publicado el 11 de junio de 2012

Past, present, and future challenges in breast cancer treatment

artículo científico publicado en 2014

Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx

scientific article published on 09 April 2020

Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group

artículo científico publicado en 2018

Persistent upregulation of U6:SNORD44 small RNA ratio in the serum of breast cancer patients

artículo científico publicado en 2011

Personalized Decision Making in Early Stage Breast Cancer: Applying Clinical Prediction Models for Anthracycline Cardiotoxicity and Breast Cancer Mortality Demonstrates Substantial Heterogeneity of Benefit-Harm Trade-off

artículo científico publicado en 2019

Phase I safety, pharmacokinetic and pharmacodynamic studies of 2-methoxyestradiol alone or in combination with docetaxel in patients with locally recurrent or metastatic breast cancer

artículo científico publicado en 2006

Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193).

artículo científico publicado en 2003

Pilot trial of paclitaxel-trastuzumab adjuvant therapy for early stage breast cancer: a trial of the ECOG-ACRIN cancer research group (E2198)

artículo científico publicado en 2015

Poly(ADP-Ribose) polymerase inhibition: "targeted" therapy for triple-negative breast cancer

artículo científico publicado en 2010

Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update

artículo científico publicado en 2016

Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update

Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update

Predicting early brain metastases based on clinicopathological factors and gene expression analysis in advanced HER2-positive breast cancer patients.

artículo científico publicado en 2015

Predicting fear of breast cancer recurrence and self-efficacy in survivors by age at diagnosis

artículo científico publicado en 2012

Predicting response to primary chemotherapy: gene expression profiling of paraffin-embedded core biopsy tissue

artículo científico publicado en 2006

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

artículo científico publicado en 2010

Prognostic and predictive value of tumor vascular endothelial growth factor gene amplification in metastatic breast cancer treated with paclitaxel with and without bevacizumab; results from ECOG 2100 trial

artículo científico publicado en 2013

Prognostic characteristics in hormone receptor-positive advanced breast cancer and characterization of abemaciclib efficacy

artículo científico publicado en 2018

Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features

artículo científico publicado en 2008

Prognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcinoma: results from the Eastern Cooperative Oncology Group E2197 study

artículo científico publicado en 2012

Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199.

artículo científico publicado en 2014

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer

artículo científico publicado en 2015

Protein kinase C-beta as a therapeutic target in breast cancer.

artículo científico publicado en 2006

Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial

artículo científico publicado en 2012

Race, ethnicity and clinical outcomes in hormone receptor-positive, HER2-negative, node-negative breast cancer in the randomized TAILORx trial

artículo científico publicado en 2020

Radiosynthesis of [11C]Vandetanib and [11C]chloro-Vandetanib as new potential PET agents for imaging of VEGFR in cancer ⬇️

artículo científico publicado el 20 de abril de 2011

Radiosynthesis of carbon-11-labeled camptothecin derivatives as potential positron emission tomography tracers for imaging of topoisomerase I in cancers

artículo científico publicado en 2005

Randomized phase II trial of the anti-angiogenic potential of doxorubicin and docetaxel; primary chemotherapy as Biomarker Discovery Laboratory

artículo científico publicado en 2005

Randomized study of Lapatinib alone or in combination with trastuzumab in women with ErbB2-positive, trastuzumab-refractory metastatic breast cancer

artículo científico publicado en 2010

Relationship between Quantitative GRB7 RNA Expression and Recurrence after Adjuvant Anthracycline Chemotherapy in Triple-Negative Breast Cancer ⬇️

artículo científico publicado el 20 de septiembre de 2011

Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast Cancer

artículo científico publicado en 2009

Reply to L.B. Marks et al.

artículo científico publicado en 2017

Resistance in the anti-angiogenic era: nay-saying or a word of caution?

artículo científico publicado en 2003

Restoring chemotherapy and hormone therapy sensitivity by parthenolide in a xenograft hormone refractory prostate cancer model

artículo científico publicado en 2006

Sequenced compared with simultaneous anthracycline and cyclophosphamide in high-risk stage I and II breast cancer: final analysis from INT-0137 (S9313).

artículo científico publicado en 2007

Simple synthesis of carbon-11 labeled styryl dyes as new potential PET RNA-specific, living cell imaging probes

artículo científico publicado en 2008

Small-molecule binding sites to explore protein-protein interactions in the cancer proteome

artículo científico publicado en 2016

Small-molecule inhibition of the uPAR·uPA interaction: Synthesis, biochemical, cellular, in vivo pharmacokinetics and efficacy studies in breast cancer metastasis ⬇️

artículo científico publicado el 9 de enero de 2013

Survival benefit needed to undergo chemotherapy: Patient and physician preferences.

artículo científico publicado en 2017

Synergistic drug combinations from electronic health records and gene expression

artículo científico publicado en 2016

Synthesis and preliminary biological evaluation of MMP inhibitor radiotracers [11C]methyl-halo-CGS 27023A analogs, new potential PET breast cancer imaging agents.

artículo científico publicado en 2002

Synthesis and preliminary biological evaluation of new carbon-11 labeled tetrahydroisoquinoline derivatives as SERM radioligands for PET imaging of ER expression in breast cancer

artículo científico publicado en 2008

Synthesis of 2-[11C]methoxy-3,17β-O,O-bis(sulfamoyl)estradiol as a new potential PET agent for imaging of steroid sulfatase (STS) in cancers ⬇️

artículo científico publicado el 19 de abril de 2012

Synthesis of [11C]Iressa as a new potential PET cancer imaging agent for epidermal growth factor receptor tyrosine kinase

artículo científico publicado en 2006

Synthesis of [18F]SU11248, a new potential PET tracer for imaging cancer tyrosine kinase

artículo científico publicado en 2005

Synthesis of [18F]Xeloda as a novel potential PET radiotracer for imaging enzymes in cancers

artículo científico publicado en 2004

Synthesis of carbon-11 labeled biaryl 1,2,3,4-tetrahydroisoquinoline derivatives and conformationally flexible analogues as new potential PET glioma tumor imaging agents

artículo científico publicado en 2007

Synthesis of carbon-11 labeled fluorinated 2-arylbenzothiazoles as novel potential PET cancer imaging agents

artículo científico publicado en 2006

Synthesis of carbon-11 labeled sulfonanilide analogues as new potential PET agents for imaging of aromatase in breast cancer

artículo científico publicado en 2006

Synthesis of carbon-11-labeled casimiroin analogues as new potential PET agents for imaging of quinone reductase 2 and aromatase expression in breast cancer

artículo científico publicado en 2010

Synthesis of carbon-11-labeled tricyclic necroptosis inhibitors as new potential PET agents for imaging of tumor necrosis factor alpha (TNF-alpha)

scientific article published on 05 May 2010

Synthesis of new carbon-11 labeled cyclofenil derivatives for PET imaging of breast cancer estrogen receptors

artículo científico publicado en 2007

Synthesis of new carbon-11 labeled naphthalene-sulfonamides for PET imaging of human CCR8

scientific article published on 20 March 2008

Synthesis of radiolabeled biphenylsulfonamide matrix metalloproteinase inhibitors as new potential PET cancer imaging agents

artículo científico publicado en 2003

Synthesis of radiolabeled protein disulfide isomerase (PDI) inhibitors as new potential PET agents for imaging of the enzyme PDI in neurological disorders and cancer ⬇️

artículo científico publicado el 8 de enero de 2013

Synthesis of radiolabeled stilbene derivatives as new potential PET probes for aryl hydrocarbon receptor in cancers

artículo científico publicado en 2006

Synthesis, biodistribution and micro-PET imaging of a potential cancer biomarker carbon-11 labeled MMP inhibitor (2R)-2-[[4-(6-fluorohex-1-ynyl)phenyl]sulfonylamino]-3-methylbutyric acid [11C]methyl ester ⬇️

artículo científico publicado el 1 de octubre de 2003

Synthesis, biodistribution and micro-PET imaging of radiolabeled antimitotic agent T138067 analogues.

artículo científico publicado en 2004

TOP2A RNA expression and recurrence in estrogen receptor-positive breast cancer ⬇️

artículo científico publicado el 16 de junio de 2012

Targeting Multiple Conformations Leads to Small Molecule Inhibitors of the uPAR·uPA Protein–Protein Interaction That Block Cancer Cell Invasion ⬇️

artículo científico publicado el 29 de septiembre de 2011

Taxanes alone or in combination with anthracyclines as first-line therapy of patients with metastatic breast cancer.

artículo científico publicado en 2008

Telomerase template antagonist GRN163L disrupts telomere maintenance, tumor growth, and metastasis of breast cancer

scientific article published on 01 May 2006

The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor-Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy-MONARCH 2: A Randomized Clinical Trial

artículo científico publicado en 2019

The Indiana University telephone-based assessment of neuropsychological status: a new method for large scale neuropsychological assessment

scientific article published on September 2007

The effects of oncotype DX recurrence scores on chemotherapy utilization in a multi-institutional breast cancer cohort

scientific article published on 01 January 2011

The first design and synthesis of [11C]MKC-1 ([11C]Ro 31-7453), a new potential PET cancer imaging agent

artículo científico publicado en 2010

The first synthesis of [(11)C]SB-216763, a new potential PET agent for imaging of glycogen synthase kinase-3 (GSK-3).

artículo científico publicado en 2010

The role of angiogenesis inhibition in the treatment of breast cancer

artículo científico publicado en 2006

Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 1: Late Recurrence: Current Understanding, Clinical Considerations

artículo científico publicado en 2019

Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 2: Approaches to Predict and Identify Late Recurrence, Research Directions

artículo científico publicado en 2019

Towards an immunoscore for triple negative breast cancer (TNBC): lymphocytic infiltrate predicts outcome

artículo científico publicado en 2013

Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831.

artículo científico publicado en 2014

Treatment-associated musculoskeletal and vasomotor symptoms and relapse-free survival in the NCIC CTG MA.27 adjuvant breast cancer aromatase inhibitor trial.

artículo científico publicado en 2014

Triple-negative breast cancer: risk factors to potential targets

artículo científico publicado en 2008

Use of Gene Expression Profiling and Chemotherapy in Early-Stage Breast Cancer: A Study of Linked Electronic Medical Records, Cancer Registry Data, and Genomic Data Across Two Health Care Systems

artículo científico publicado en 2016

Using natural language processing to construct a metastatic breast cancer cohort from linked cancer registry and electronic medical records data

artículo científico publicado en 2019

Virtual screening targeting the urokinase receptor, biochemical and cell-based studies, synthesis, pharmacokinetic characterization, and effect on breast tumor metastasis

artículo científico publicado en 2011

Weekly paclitaxel in the adjuvant treatment of breast cancer.

artículo científico publicado en 2008

[11C]Choline as a potential PET marker for imaging of breast cancer athymic mice

artículo científico publicado en 2002

beta-Tubulin mutations are associated with resistance to 2-methoxyestradiol in MDA-MB-435 cancer cells.

artículo científico publicado en 2005

p27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy

artículo científico publicado en 2006

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda